Schaeffer Center expert Mireille Jacobson co-authored an op-ed in STAT examining why hospitals and health systems are not investing in palliative care despite research showing this type of therapy substantially improves outcomes for patients with serious illness.
Other featured articles
Interdisciplinary Panel Offers Solutions to Improve Recruitment for Alzheimer’s Clinical Trials
Experts from the private and public sectors convened a panel to improve recruitment for Alzheimer’s clinical trials.
Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials
An advisory panel of experts convened in 2020 to assess the critical challenges facing recruitment in Alzheimer’s clinical trials and develop a set of recommendations to overcome them.
The Moderating Role of Race and Ethnicity in the Relationship Between Negative Family Interactions and Mental Health Among Older Adults
This study examines whether the association between negative family interactions and mental health outcomes varies by race and ethnicity.
Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers
Schaeffer Center experts propose two different types of payment models applicable to disease-modifying therapies in Alzheimer’s disease, and suggest four strategies to overcome challenges in their implementation.
About this section
People are living longer, which brings obvious benefits as well as considerable challenges — from Alzheimer’s and other age-related diseases to increased injuries, disabilities and poverty risks. Policymakers around the world rely on Schaeffer Center research and modeling tools for finding ways to help keep people as healthy as possible throughout their lives.